InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Tregoning Kathleen. Director active across 2 companies, notably Spero Therapeutics, Inc.. Cumulatively, 7 reports have been published. Activity tracked since 15 September 2022. The latest transaction was filed on 12 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Tregoning Kathleen is a declarant associated with Spero Therapeutics, Inc., where the listed role is Director, and with Cerevel Therapeutics Holdings, Inc., where the listed role is See Remarks. She has 7 filings in total, and in the sampled recent filings covering the period from 2022-09-19 to 2025-06-16, both buy and sell amounts are 0 EUR, with Attribution as the modal transaction nature.